基于ProMisE分子分类器和子宫内膜癌的免疫-炎症-营养评分的复发预测模型的开发和验证:一项回顾性多中心研究

Yunfeng Zheng1, Fan Yang2, Gaohua Liu3

  • 1Department of Gynecologic Oncology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China; Zhejiang Provincial Key Laboratory of Precision Diagnosis and Therapy for Major Gynecological Diseases, Hangzhou, Zhejiang, China.

概括

一个新的模型将血红蛋白,白蛋白,淋巴细胞和血小板 (HALP) 分数与ProMisE分子亚型和临床因素结合起来,准确地预测子宫内膜癌复发. 这有助于识别高风险患者进行量身定制的治疗和监测.